Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 21, 1999

View Archived Issues

Potential of RSVIG assessed in immunosuppressed animal model

Genzyme Molecular Oncology reports preclinical results, collaboration for aaATIII

Oxford GlycoSciences continues steady progress during first half

Peptide Therapeutics achieves significant milestones during first half of 1999

Chimeric anti-factor D MAb from Tanox for complement-mediated disorders

FDA okays new pediatric formulation of zafirlukast

New series of protein tyrosine kinase and cyclin-dependent kinase inhibitors

Schering AG announces intention to acquire Diatide

Propofol is highly effective in treating refractory migraine pain

New isomer of toremifene metabolite has favorable antiestrogenic and hypolipidemic effects

TNF-alpha inhibitor CNI-1493 ameliorates experimental arthritis in rats

Two new AIDS treatment options introduced in Germany

Yissum prepares two new glycinamide derivatives useful as anticonvulsants

Dofetilide restores sinus rhythm without increasing risk of death in patients with CHF

U.S. HHS describes new antitumor lavendustin A analogues

Inhibitors of monoamine reuptake revealed recently by U. of Minnesota

New target, new treatment for allergies and asthma discovered at Hughes Institute

Japanese coalition formed for development of new drugs

Kyowa Hakko begins clinical testing of MAb as melanoma Rx

Valentis and Boehringer Ingelheim establish gene medicine collaboration for rheumatoid arthritis

Rifalazil: preclinical and clinical results presented at IUATLD conference; development on hold

Japanese launch of nateglinide announced

Glaxo Wellcome's GW-9578 is the most potent PPARalpha agonist yet reported

Chinese study shows new Cl- transport inhibitor equieffective to corticosteroids in asthma

Unique cardioprotective profile of FR-168888 emerges from pharmacological studies

Mylan and Synthon enter strategic alliance

Switch Biotech awarded grant for wound-healing therapies

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 13, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance
BioWorld
Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.